Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis

AbstractBackground Pre-emptive kidney transplantation (PEKT), i.e., transplantation performed before initiation of maintenance dialysis, is considered an ideal renal replacement therapy because there is no exposure to long-term dialysis therapy. Therefore, we summarized advantages/disadvantages of P...

Full description

Bibliographic Details
Main Authors: Tatsuhiko Azegami, Noriyuki Kounoue, Tadashi Sofue, Masahiko Yazawa, Makoto Tsujita, Kosuke Masutani, Yuki Kataoka, Hideyo Oguchi
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2023.2169618
_version_ 1797658517359820800
author Tatsuhiko Azegami
Noriyuki Kounoue
Tadashi Sofue
Masahiko Yazawa
Makoto Tsujita
Kosuke Masutani
Yuki Kataoka
Hideyo Oguchi
author_facet Tatsuhiko Azegami
Noriyuki Kounoue
Tadashi Sofue
Masahiko Yazawa
Makoto Tsujita
Kosuke Masutani
Yuki Kataoka
Hideyo Oguchi
author_sort Tatsuhiko Azegami
collection DOAJ
description AbstractBackground Pre-emptive kidney transplantation (PEKT), i.e., transplantation performed before initiation of maintenance dialysis, is considered an ideal renal replacement therapy because there is no exposure to long-term dialysis therapy. Therefore, we summarized advantages/disadvantages of PEKT to assist in deciding whether kidney transplantation should be performed pre-emptively.Methods This study was registered with PROSPERO, CRD42021269163. Observational studies comparing clinical outcomes between PEKT and non-PEKT were included; those involving only pediatric recipients or simultaneous multi-organ transplantations were excluded. The PubMed/MEDLINE, Cochrane Library, and Ichushi-Web databases were searched on 1 August 2021. Studies were pooled using the generic inverse-variance method with random effects model, and risk of bias was assessed using ROBINS-I.Results Seventy-six studies were included in the systematic review (sample size, 23–121,853; enrollment year, 1968–2019). PEKT patients had lower all-cause mortality (adjusted HR: 0.78 [95% CI 0.66–0.92]), and lower death-censored graft failure (0.81 [0.67–0.98]). Unadjusted RRs for the following outcomes were comparable between the two patient groups: cardiovascular disease, 0.90 (0.58–1.40); biopsy-proven acute rejection, 0.75 (0.55–1.03); cytomegalovirus infection, 1.04 (0.85–1.29); and urinary tract infection, 0.89 (0.61–1.29). Mean differences in post-transplant QOL score were comparable in both groups. The certainty of evidence for mortality and graft failure was moderate and that for other outcomes was very low following the GRADE classification.Conclusions The present meta-analysis shows the potential benefits of PEKT, especially regarding patient and graft survival, and therefore PEKT is recommended for adults with end-stage kidney disease.
first_indexed 2024-03-11T18:00:08Z
format Article
id doaj.art-83828129558344d69d594907c72a345b
institution Directory Open Access Journal
issn 0886-022X
1525-6049
language English
last_indexed 2024-03-11T18:00:08Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj.art-83828129558344d69d594907c72a345b2023-10-17T09:23:23ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492023-12-0145110.1080/0886022X.2023.2169618Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysisTatsuhiko Azegami0Noriyuki Kounoue1Tadashi Sofue2Masahiko Yazawa3Makoto Tsujita4Kosuke Masutani5Yuki Kataoka6Hideyo Oguchi7Keio University Health Center, Yokohama, JapanDepartment of Nephrology, Toho University Faculty of Medicine, Tokyo, JapanDepartment of Cardiovascular and Cerebrovascular Medicine, Kagawa University, Takamatsu, JapanDepartment of Nephrology and Hypertension, St Marianna University School of Medicine, Kawasaki, JapanDepartment of Nephrology, Masuko Memorial Hospital, Nagoya, JapanDepartment of Internal Medicine, Faculty of Medicine, Division of Nephrology and Rheumatology, Fukuoka University, Fukuoka, JapanDepartment of Internal Medicine, Kyoto Min-Iren Asukai Hospital, Kyoto, JapanDepartment of Nephrology, Toho University Faculty of Medicine, Tokyo, JapanAbstractBackground Pre-emptive kidney transplantation (PEKT), i.e., transplantation performed before initiation of maintenance dialysis, is considered an ideal renal replacement therapy because there is no exposure to long-term dialysis therapy. Therefore, we summarized advantages/disadvantages of PEKT to assist in deciding whether kidney transplantation should be performed pre-emptively.Methods This study was registered with PROSPERO, CRD42021269163. Observational studies comparing clinical outcomes between PEKT and non-PEKT were included; those involving only pediatric recipients or simultaneous multi-organ transplantations were excluded. The PubMed/MEDLINE, Cochrane Library, and Ichushi-Web databases were searched on 1 August 2021. Studies were pooled using the generic inverse-variance method with random effects model, and risk of bias was assessed using ROBINS-I.Results Seventy-six studies were included in the systematic review (sample size, 23–121,853; enrollment year, 1968–2019). PEKT patients had lower all-cause mortality (adjusted HR: 0.78 [95% CI 0.66–0.92]), and lower death-censored graft failure (0.81 [0.67–0.98]). Unadjusted RRs for the following outcomes were comparable between the two patient groups: cardiovascular disease, 0.90 (0.58–1.40); biopsy-proven acute rejection, 0.75 (0.55–1.03); cytomegalovirus infection, 1.04 (0.85–1.29); and urinary tract infection, 0.89 (0.61–1.29). Mean differences in post-transplant QOL score were comparable in both groups. The certainty of evidence for mortality and graft failure was moderate and that for other outcomes was very low following the GRADE classification.Conclusions The present meta-analysis shows the potential benefits of PEKT, especially regarding patient and graft survival, and therefore PEKT is recommended for adults with end-stage kidney disease.https://www.tandfonline.com/doi/10.1080/0886022X.2023.2169618Transplantationmeta-analysissystematic reviewpre-emptive kidney transplantationmortalitygraft failure
spellingShingle Tatsuhiko Azegami
Noriyuki Kounoue
Tadashi Sofue
Masahiko Yazawa
Makoto Tsujita
Kosuke Masutani
Yuki Kataoka
Hideyo Oguchi
Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis
Renal Failure
Transplantation
meta-analysis
systematic review
pre-emptive kidney transplantation
mortality
graft failure
title Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis
title_full Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis
title_fullStr Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis
title_full_unstemmed Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis
title_short Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis
title_sort efficacy of pre emptive kidney transplantation for adults with end stage kidney disease a systematic review and meta analysis
topic Transplantation
meta-analysis
systematic review
pre-emptive kidney transplantation
mortality
graft failure
url https://www.tandfonline.com/doi/10.1080/0886022X.2023.2169618
work_keys_str_mv AT tatsuhikoazegami efficacyofpreemptivekidneytransplantationforadultswithendstagekidneydiseaseasystematicreviewandmetaanalysis
AT noriyukikounoue efficacyofpreemptivekidneytransplantationforadultswithendstagekidneydiseaseasystematicreviewandmetaanalysis
AT tadashisofue efficacyofpreemptivekidneytransplantationforadultswithendstagekidneydiseaseasystematicreviewandmetaanalysis
AT masahikoyazawa efficacyofpreemptivekidneytransplantationforadultswithendstagekidneydiseaseasystematicreviewandmetaanalysis
AT makototsujita efficacyofpreemptivekidneytransplantationforadultswithendstagekidneydiseaseasystematicreviewandmetaanalysis
AT kosukemasutani efficacyofpreemptivekidneytransplantationforadultswithendstagekidneydiseaseasystematicreviewandmetaanalysis
AT yukikataoka efficacyofpreemptivekidneytransplantationforadultswithendstagekidneydiseaseasystematicreviewandmetaanalysis
AT hideyooguchi efficacyofpreemptivekidneytransplantationforadultswithendstagekidneydiseaseasystematicreviewandmetaanalysis